Summary
Unlike other areas of research into arthritis, it is pleasing to record independent work leading to convergence of ideas instead of divergence and increasing complexity. Catabolin is now identified with interleukin-1, although there is case for the retention of the original name to describe its chondrocyte-stimulating function with subsequent matrix degradation. In 10 years, catabolin/interleukin-1 research has yielded much information about cellular interactions within the arthritic joint and has provided a probe with which the intricacies of matrix metabolism are being unravelled. In future, there are prospects of characterizing the naturally occurring inhibitors and developing new compounds which influence the actions of catabolin/IL-1 to the benefit of the patient with arthritis.
Similar content being viewed by others
References
Fell HB, Jubb RW (1977) The effect of synovial tissue on the breakdown of articular cartilage in organ culture. Arthritis Rheum 20:1359–1371
Aarden LA, Brunner TK, Cerottini JC et al (1979) Revised nomenclature for antigen non-specific T cell proliferation and helper factors. J Immunol 123:2928–2929
Dinarello CA (1984) Interleukin-1. Rev Infect Dis 6:51–95
Nuki G, Duff G (eds) Interleukin-1. Proceedings of BSR/ARC International Symposium and Workshop, London, 1984. Br J Rheumatol vn24 (suppl):1–37
Steinberg J, Sledge CB, Noble J, Stirrat R (1979) A tissue culture model of cartilage breakdown in rheumatoid arthritis. Biochem J 180:403–412
Steinberg J, Tsukamoto S, Sledge C (1983) Breakdown of cartilage proteoglycan in a tissue culture model of rheumatoid arthritis. Biochim Biophys Acta 757:47–56
Steinberg J, Kincaid SB, Sledge CB (1983) Inhibition of cartilage breakdown by hydrocortisone in a tissue culture model of rheumatoid arthritis. Ann Rheum Dis 42:323–330
Kobayashi I, Ziff M (1975) Electron microscope studies of the cartilage-pannus junction in rheumatoid arthritis. Arthritis Rheum 18:475–483
Dingle JT, Saklatvala J, Hembry R, Tyler J, Fell HB, Jubb R (1979) A cartilage catabolic factor from synovium. Biochem J 184:177–180
Jones I, McGuire MB, Klamfeldt A (1982) Enhanced breakdown of bovine articular cartilage proteoglycans by conditioned synovial medium in vitro: A possible role for prostaglandins. Scand J Rheumatol 11:177–183
Saklatvala J, Sarsfield SJ, Pilsworth LMC (1983) Characterization of proteins from human synovium and mononuclear leucocytes that induce resorption of cartilage proteoglycan in vitro. Biochem J 209:337–344
Sandy JD, Brown HLG, Lowther DA (1978) Degradation of proteoglycan in articular cartilage. Biochem Biophys Acta 543:536–544
Dingle JT, Qi E (1983) Intracellular catabolin-like activity in cultured synovial tissue. In vitro 19:892–896
Pilsworth LMC, Saklatvala J (1983) The cartilage resorbing protein catabolin is made by synovial fibroblasts and its production is increased by phorbol myristate acetate. Biochem J 216:481–489
Barland P, Novikoff AB, Hamerman D (1962) Electron microscopy of human synovial membrane. J Cell Biol 14:207–220
Jones IL, Klamfeldt A, McGuire MB (1982) Enhanced breakdown of bovine articular cartilage proteoglycans by conditioned synovial medium. The effect of serum and dextran sulphate. Scand J Rheumatol 11:41–46
Saklatvala J (1981) Characterization of catabolin, the major product of pig synovial tissue that induces resorption of cartilage proteoglycan in vitro. Biochem J 199:705–714
Saklatvala J, Curry VA, Sarsfield SJ (1983) Purification to homogeneity of pig leucocyte catabolin, a protein that causes cartilage resorption in vitro. Biochem J 215:385–392
Saklatvala J, Pilsworth LMC, Sarsfield SJ, Gavrilovic J, Heath JK (1984) Pig catabolin is a form of interleukin-1. Biochem J 224:461–466
Saklatvala J, Sarsfield SJ, Townsend Y (1985) Pig interleukin-1. J Exp Med 162:1208–1222
Dayer M, Robinson DR, Krane SM (1977) Prostaglandin production by rheumatoid synovial cells: stimulation by a factor from human mononuclear cells. J Exp Med 145:1399–1404
Deshmukh-Phadke K, Lawrence M, Nanda S (1978) Synthesis of collagenase and neutral proteases by articular chondrocytes: stimulation by a macrophage derived factor. Biochim Biophys Res Commun 85:490–496
Meats JE, McGuire MB, Russell RG (1980) Human synovium releases a factor which stimulates chondrocyte production of prostaglandins and plasminogen activator. Nature 286:891–892
Mizel SB, Dayer JM, Krane SM, Mergenhagen SE (1981) Stimulation of rheumatoid synovial cell collagenase and prostaglandin production by partially purified lymphocyte activating factor (IL-1). Proc Natl Acad Sci USA 78:2474–2477
McGuire-Goldring MB, Meats JE, Wood DD, Ihrie EJ, Ebsworth NM, Russell RG (1984) In vitro activation of human chondrocytes and synoviocytes by a human interleukin-1 like factor. Arthritis Rheum 27:654–662
Elford PR, Meats JE, Sharrard RM, Russell RG (1985) Partial purification of a factor from human synovium that possesses interleukin-1, chondrocyte stimulating and catabolin-like activities. FEBS Lett 179:247–251
Wood DD, Bayne EK, Goldring MB, Gowen M, Hamerman D, Humes JL, Ihrie EJ, Lipsky PE, Staruch MJ (1985) The four biochemically distinct species of human interleukin-1 all exhibit similar biologic activities. J Immunol 134:895–903
Saklatvala J (1986) Tumour necrosis factor alpha stimulates resorption and inhibits synthesis of proteoglycan in cartilage. Nature 322:547–549
Bertolini DR, Nedwin GE, Bringman TS, Smith DD, Mundy GR (1986) Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factor. Nature 319:516–518
Farndale RW, Sayers C, Barrett AJ (1982) A direct spectrophotometric microassay for sulfated glycosaminoglycans in cartilage culture. Connect Tissue Res 9:247–248
Sheppeard H, Pilsworth LMC, Hazleman B, Dingle JT (1982) Effects of antirheumatoid drugs on the production and action of porcine catabolin. Ann Rheum Dis 41:463–468
Couchman KG, Sheppeard H (1986) The effect of antirheumatic drugs on factors from porcine synovium inducing chondrocyte mediated cartilage degradation. Agents Actions 19:116–122
Tyler JA, Fell HB, Lawrence CE (1982) Effect of cortisol on porcine articular tissues in organ culture. J Pathol 137:335–351
Tiku ML, Liu S, Tiku K (1986) Effect of interleukin-1 on antigen presentation by normal articular chondrocytes. Arthritis Rheum 29 (suppl) (abstr 26)
Herman JH, Appel AM, Hess EV (1985) Catabolins in osteoarthritis: in vivo and in vitro effects of piroxicam. Proc 16th Int Congr Rheumatol, Sydney (abstr P 458)
Saklatvala J, Dingle JT (1980) Identification of catabolin, a protein from synovium which induces degradation of cartilage in organ culture. Biochim Biophys Res Commun 96:1225–1231
Whiteside TL, Worral JG, Prince RK, Buckingham RB, Rodnam GP (1985) Soluble mediators from mononuclear cells increase the synthesis of glycosaminoglycans by dermal fibroblast cultures derived from normal subjects and progressive systemic sclerosis patients. Arthritis Rheum 28:188–197
Decker RS, Dingle JT (1982) Cardiac catabolic factors: the degradation of heart valve intercellular matrix. Science 215:987–989
Dingle JT, Dingle TT (1980) The site of cartilage matrix degradation. Biochem J 190:431–438
Dingle JT, Horsfield P, Fell HB, Barratt MEJ (1975) Breakdown of proteoglycan and collagen induced in pig articular cartilage in organ culture. Ann Rheum Dis 34:303–311
Tyler JA (1985) Chondrocyte mediated depletion of articular cartilage proteoglycans in vitro. Biochem J 225:493–507
Tyler JA (1985) Articular cartilage cultured with catabolin (pig interleukin-1) synthesises a decreased number of normal proteoglycan molecules. Biochem J 227:869–878
Carrol GJ (1986) A study of the effects of catabolin on cyclic adenosine monophosphate biosynthesis and prostaglandin E2 secretion in pig articular chondrocytes. Br J Rheumatol 25:359–365
Klempner MS, Dinarello CA, Henderson WR, Gallin JI (1979) Stimulation of neutrophil oxygen-dependent metabolism by human leukocytic pyrogen. J Clin Invest 64:996–1002
Greenwald RA, Moy WW, Lazarus D (1976) Degradation of cartilage proteoglycan and collagen by superoxide radical. Arthritis Rheum 19:799 (abstr)
Greenwald M, Yamaguchi D, Hahn T (1986) Potential intracellular mechanisms for the biological effects of interleukin-1 on bone cells. Arthritis Rheum 29 (suppl) (abstr 5)
Stastny P, Rosenthal M, Andreis M, Ziff M (1975) Lymphokines in the rheumatoid joint. Arthritis Rheum 18:237–243
Moore RN, Oppenheim JJ, Farrar JJ, Carter CS, Waheed A, Shadduck RK (1980) Production of LAF (IL-1) by macrophages activated with colony stimulating factors. J Immunol 125:1302–1305
Wood DD, Ihrie EJ, Dinarello CA, Cohen PL (1983) Isolation of an interleukin-1-like factor from human joint effusions. Arthritis Rheum 26:975–983
Nouri AM, Panayi GS, Goodman SM (1984) Cytokines and the chronic inflammation of rheumatic disease. I: The presence of interleukin-1 in synovial fluids. Clin Exp Immunol 55:295–302
Bendtzen K, Petersen J, Kristensen JH, Hansen TI (1985) Interleukin-1-like activities in synovial fluids of patients with rheumatoid arthritis and traumatic synovitis. Rheumatol Int 5:79–82
Miossec P, Dinarello CA, Ziff M (1986) Interleukin-1 lymphocyte chemotactic activity in rheumatoid arthritis synovial fluid. Arthritis Rheum 29:461–469
Ramsay C, Giovine FD, Forster P, Nuki G, Duff G (1986) Inhibition of IL-1 T-cell mitogenesis by synovial exudate fluids from patients with RA and OA. Br J Rheumatol 25 (suppl 2) (abstr 30)
Ehrlich MG, Mankin HJ, Jones H, Wright R, Crispen C, Vigliani G (1977) Collagenase and collagenase inhibitor in osteoarthritic and normal human cartilage. J Clin Invest 59:226–233
Cannon JG, Dinarello CA (1985) Increased plasma interleukin-1 activity in women after ovulation. Science 227:1247–1249
Cannon JG, Kluger MJ (1983) Endogenous pyrogen activity in human plasma after exercise. Science 220:617–619
Gahring L, Baltz M, Pepys MB, Daynes R (1984) Effect of ultra-violet radiation on production of epidermal cell thymocyte activating factor/interleukin-1 in vivo and in vitro. Proc Natl Acad Sci USA 81:1198–1202
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sheppeard, H., Couchman, K.G. What's happened to catabolin?. Rheumatol Int 7, 141–145 (1987). https://doi.org/10.1007/BF00270361
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00270361